Bohbot V., Lerch J., Thorndycraft B., Iaria G., Zijdenbos A. P. (2007). Gray matter differences correlate with spontaneous strategies in a human virtual navigation task, J Neurosci, 27(38), 10078-83.

Bowles B., Crupi C., Mirsattari S. M., Pigott S. E., Parrent A. G., Pruessner J., Yonelinas A. P., Kohler S. (2007). Impaired familiarity with preserved recollection after anterior temporal-lobe resection that spares the hippocampus, Proc Natl Acad Sci U S A, 104(41), 16382-7.

Brouillette J., Quirion R. (2007). Transthyretin: A key gene involved in the maintenance of memory capacities during aging, Neurobiol Aging.

Brouillette J., Young D., During M. J., Quirion R. (2007). Hippocampal gene expression profiling reveals the possible involvement of Homer1 and GABA(B) receptors in scopolamine-induced amnesia, J Neurochem, 102(6), 1978-89.

Burns A., Gauthier S., Perdomo C. (2007). Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease, Int J Geriatr Psychiatry, 22(8), 806-12.

Buss C., Lord C., Wadiwalla M., Hellhammer D. H., Lupien S. J., Meaney M., Pruessner J. (2007). Maternal care modulates the relationship between prenatal risk and hippocampal volume in women but not in men, J Neurosci, 27(10), 2592-5.

Cai M., Chen T., Quirion R., Hong Y. (2007). The involvement of spinal bovine adrenal medulla 22-like peptide, the proenkephalin derivative, in modulation of nociceptive processing, Eur J Neurosci, 26(5), 1128-38.

Camicioli R., Gauthier S. (2007). Clinical trials in Parkinson's disease dementia and dementia with Lewy bodies, Can J Neurol Sci, 34 Suppl 1, S109-17.

Carvajal C., Dumont Y., Quirion R. (2007). Neuropeptide Y . Dans Fink G. (Éd.) , Encyclopedia of Stress (pp. 895-903). Academic Press.

Corin E., Gauthier S., Rousseau R. (2007). Le médicament, ses reliefs et ses ombres sur la scène de la clinique transculturelle, Can J Commun Ment Health, 26(2), 37-51.

Dandeneau S. D., Baldwin M. W., Baccus J. R., Sakellaropoulo M., Pruessner J. (2007). Cutting stress off at the pass: reducing vigilance and responsiveness to social threat by manipulating attention, J Pers Soc Psychol, 93(4), 651-66.

Dubois B., Burn D., Goetz C., Aarsland D., Brown T., Broe G. A., Dickson D., Duyckaerts C., Cummings J., Gauthier S., Korczyn A., Lees A., Levy R., Litvan I., Mizuno Y., McKeith I. G., Olanow C. W., Poewe W., Sampaio C., Tolosa E., Emre M. (2007). Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force, Mov Disord, 22(16), 2314-24.

Dubois B., Feldman H. H., Jacova C., Dekosky S. T., Barberger-Gateau P., Cummings J., Delacourte A., Galasko D., Gauthier S., Jicha G., Meguro K., O'Brien J., Pasquier F., Robert P., Rossor M., Salloway S., Stern Y., Visser P. J., Scheltens P. (2007). Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria, Lancet Neurol, 6(8), 734-46.

Dumont Y., Moyse E., Fournier A., Quirion R. (2007). Distribution of Peripherally Injected Peptide YY ([(125)I] PYY (3-36)) and Pancreatic Polypeptide ([ (125)I] hPP) in the CNS: Enrichment in the Area Postrema, J Mol Neurosci, 33(3), 294-304.

Emre M., Aarsland D., Brown T., Burn D. J., Duyckaerts C., Mizuno Y., Broe G. A., Cummings J., Dickson D. W., Gauthier S., Goldman J., Goetz C., Korczyn A., Lees A., Levy R., Litvan I., McKeith I., Olanow W., Poewe W., Quinn N., Sampaio C., Tolosa E., Dubois B. (2007). Clinical diagnostic criteria for dementia associated with Parkinson's disease, Mov Disord, 22(12), 1689-707; quiz 1837.

Etchamendy N., Bohbot V. (2007). Spontaneous navigational strategies and performance in the virtual town, Hippocampus, 17(8), 595-9.

Ferreri F., Agbokou C., Gauthier S. (2007). [Cardiovascular effects of cholinesterase inhibitors in Alzheimer's disease], Rev Neurol (Paris), 163(10), 968-74.

Fiocco A. J., Joober R., Poirier J., Lupien S. J. (2007). Polymorphism of the 5HT2A Receptor Gene: Association with Stress-Related Indices in Healthy Baby Boomers, Frontier Behavior. Neurosci, 1(3), 1-7.

Gauthier S. (2007). Outcomes for assessment of symptomatic and stabilization/disease modifying drugs, Can J Neurol Sci, 34 Suppl 1, S23-6.

Gauthier S., Erkinjutti T., Rockwood K. (2007). Vascular dementia . Dans Ritchie C. W, Ames D., Masters. C. L. , Cummings J. & Ritchie C. W (Éds.) , TherapeuticStrategies in Dementia (pp. 273-286). Clinical Publishing.